ECG Belt for CRT Response
1 other identifier
interventional
498
7 countries
43
Brief Summary
The purpose of this clinical study is to compare ECG Belt Research System managed cardiac resynchronization therapy (CRT) patients and a control CRT group with respect to left ventricular (LV) remodeling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable heart-failure
Started Jul 2018
Typical duration for not_applicable heart-failure
43 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2018
CompletedFirst Posted
Study publicly available on registry
April 20, 2018
CompletedStudy Start
First participant enrolled
July 13, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 7, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2022
CompletedResults Posted
Study results publicly available
February 3, 2023
CompletedFebruary 3, 2023
January 1, 2023
3.5 years
April 12, 2018
December 22, 2022
January 31, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Left Ventricular End Systolic Volume (LVESV) From Baseline to 6 Months Post-implant.
Relative (%) change in LVESV from the baseline measurement to the 6 month measurement.
baseline to 6 months
Study Arms (2)
ECG Belt
EXPERIMENTALThe ECG Belt arm will utilize the ECG Belt Research System at implant and all follow up visits.
Control Arm
NO INTERVENTIONStandard CRT through 6 months follow-up.
Interventions
The ECG Belt Research System is used to identify the best vector and programming parameters.
Eligibility Criteria
You may qualify if:
- Indicated for CRT, with QRS duration ≥130 ms, and planned to be implanted with a market-released Medtronic CRT device with AdaptivCRT and a Medtronic quadripolar LV lead.
- Meets at least one of the following criteria: QRS duration \< 150 ms, Prior documented Myocardial Infarction, Non-LBBB
- LVEDD ≥ 55 mm, as determined by site
You may not qualify if:
- Permanent/persistent AF or presenting with AF
- Pre-existing or previous LV lead or other confounding devices e.g. Left Ventricular Assist Device, Vagal Nerve Stimulator
- Currently implanted with IPG or ICD with \> 10% RV pacing
- Permanent complete AV block
- Enrolled in a concurrent study that may confound the results of this study. Pre-approval from the study manager is required for enrollment of a patient that is in a concurrent study.
- Less than 1 year life expectancy
- Vulnerable adults
- Younger than 18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (43)
Hartford Hospital
Hartford, Connecticut, 06102, United States
Yale School of Medicine
New Haven, Connecticut, 06510, United States
MedStar Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
University of Florida Health Shands Hospital
Gainesville, Florida, 32608, United States
Florida Hospital Cardiovascular Research Institute
Orlando, Florida, 32803-1248, United States
BayCare Health System
Tampa, Florida, 33614-7101, United States
NorthShore University Health System
Evanston, Illinois, 60201-1718, United States
Iowa Heart Center
West Des Moines, Iowa, 50266, United States
Heartland Cardiology
Wichita, Kansas, 67205-1138, United States
Cardiovascular Institute of the South
Houma, Louisiana, 70360, United States
Advanced Cardiovascular Specialists
Shreveport, Louisiana, 71105, United States
Mayo Clinic
Rochester, Minnesota, 55905, United States
Saint Lukes Hospital of Kansas City
Kansas City, Missouri, 64111, United States
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Bryan Heart
Lincoln, Nebraska, 68506, United States
Morristown Memorial Hospital
Morristown, New Jersey, 07960-6136, United States
Atrium Health's Carolina Medical Center
Charlotte, North Carolina, 28203-5867, United States
Duke University Medical Center
Durham, North Carolina, 27710, United States
North Carolina Heart and Vascular
Raleigh, North Carolina, 27607-7521, United States
Cleveland Clinic
Cleveland, Ohio, 44195, United States
Mount Carmel East
Columbus, Ohio, 43213, United States
OhioHealth Research and Innovation Institute (OHRI)
Columbus, Ohio, 43214, United States
Oklahoma Heart Hospital
Oklahoma City, Oklahoma, 73120, United States
Lehigh Valley Hospital- Cedar Crest
Allentown, Pennsylvania, 18103, United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
University of Pittsburgh Medical Center UPMC Presbyterian
Pittsburgh, Pennsylvania, 15213-2536, United States
Geisinger Wyoming Valley Medical Center
Wilkes-Barre, Pennsylvania, 18711, United States
Medical University of South Carolina
Charleston, South Carolina, 29425-0001, United States
Wellmont CVA Heart Institute
Kingsport, Tennessee, 37660-7332, United States
Vanderbilt University medical Center
Nashville, Tennessee, 37232-8802, United States
Texas Cardiac Arrhythmia Research Foundation
Austin, Texas, 78705, United States
Texas Health Research & Education Institute
Fort Worth, Texas, 76104, United States
The University of Vermont Medical Center
Burlington, Vermont, 05401-1473, United States
Aurora St. Lukes
Milwaukee, Wisconsin, 53215, United States
Onze-Lieve-Vrouwziekenhuis-campus aalst
Aalst, 9300, Belgium
Cliniques Universitaires Saint-Luc
Brussels, 1200, Belgium
University of Ottawa Heart Institute
Ottawa, Ontario, K1Y 4W7, Canada
Montreal Heart Institute
Montreal, Quebec, H1T 1C8, Canada
Rigshospitalet
Copenhagen, 2100, Denmark
Policlinico Sant' Orsola - Malpighi
Bologna, 40138, Italy
Istituto Auxologico Italiano - Istituto Scientifico Ospedale San Luca
Milan, 20149, Italy
Maastricht Universitair Medisch Centrum (MUMC)
Maastricht, 6229 HX, Netherlands
Centre Hospitalier Universitaire Vaudois
Lausanne, 1011, Switzerland
Related Publications (2)
Rickard J, Jackson K, Biffi M, Vernooy K, Bank A, Cerkvenik J, Ghosh S, Gold MR. The ECG Belt for CRT response trial: Design and clinical protocol. Pacing Clin Electrophysiol. 2020 Oct;43(10):1063-1071. doi: 10.1111/pace.13985. Epub 2020 Sep 1.
PMID: 32537740RESULTRickard J, Jackson K, Gold M, Biffi M, Ziacchi M, Silverstein J, Ramza B, Metzl M, Grubman E, Abben R, Varma N, Tabbal G, Jensen C, Wouters G, Ghosh S, Vernooy K; ECG Belt for CRT Response Study Group. Electrocardiogram Belt guidance for left ventricular lead placement and biventricular pacing optimization. Heart Rhythm. 2023 Apr;20(4):537-544. doi: 10.1016/j.hrthm.2022.11.015. Epub 2022 Nov 25.
PMID: 36442824RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- CRM Clinical
- Organization
- Medtronic CRM Clincial Research
Study Officials
- STUDY CHAIR
ECG Belt for CRT Response Clinical Research Specialist
Medtronic
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 12, 2018
First Posted
April 20, 2018
Study Start
July 13, 2018
Primary Completion
January 7, 2022
Study Completion
April 20, 2022
Last Updated
February 3, 2023
Results First Posted
February 3, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share